Disparities Found in HIV Prevention Among Different Groups of Black Women

Fewer black women are being diagnosed with HIV, but new research finds the gains are not equally distributed among all black women.

Hanna Demeke, RN, PhD, the lead author of the study, said while the overall news for black women is good when it comes to HIV, foreign-born black women aren’t benefiting from HIV prevention programs at the same rates as other women.

“The analysis of annual diagnosis among black women in the US from 2008 to 2016 found that while diagnosis rates declined among all black women during this time period, the smallest decline was among non-US-born groups of black women,” Demeke told MD Magazine®. “When looking at disparities, absolute disparities declined for both US-born and non-US-born black women, however the relative disparity increased for non-US-born black women.”

Demeke works at the Centers for Disease Control and Prevention’s National Center for HIV/AIDS, Viral Hepatitis, STD, and TB Prevention.

Between 2008 and 2016, 10,531 white women were diagnosed with HIV, and 39,333 black women were diagnosed with the virus. Those numbers are based on the National HIV Surveillance System and are limited to women for whom complete country-of-birth information was known. Of the white women diagnosed with HIV, just 4% were born in another country.

However, among the black women diagnosed with HIV, more than 1 in 5 (21.4%) were foreign born. Of the latter group, 61.9% were born in Africa, and 33.9% were born in the Caribbean.

Demeke said better HIV therapies are 1 likely reason overall HIV diagnoses are dropping.

Those include antiretroviral therapies that can suppress the virus to the point where it’s undetectable and untransmittable —as well as pre-exposure prophylaxis (PrEP)—which can be taken by an HIV-negative partner to prevent transmission.

Demeke also noted other research has shown factors, such as an overall drop in STDs among black women and a drop in HIV infections among black men, are also likely at play.

As for why foreign-born women seem to be lagging behind, Demeke said the data in the study were not focused on determining such causes. She said it’s also not known whether these women were contracting HIV before or after coming to the US.

However, she said there’s some evidence that non-US-born women may be less aware of their personal risk regarding HIV.

“Additionally, wariness of initiating HIV care due to fears related to immigration status and HIV-related stigma may prevent non-US-born women from accessing basic HIV prevention services, such as HIV counseling and testing,” she noted.

Though the exact causes of the disparity are unknown, Demeke said the takeaways are not. One key takeaway: black women shouldn’t be treated like a monolithic group.

“Accounting for the heterogeneity of the US black women’s populations is crucial in measuring and monitoring progress toward eliminating health disparities and helping tailor strategies, interventions, and programs aimed at reducing disparities in HIV diagnosis,” she said.

Among the strategies to tackle the problem, Demeke suggested expanding access to biomedical and behavioral interventions, as well as “culturally sensitive research guided by social and structural determinants frameworks.”

Demeke added that public health agencies need to ensure their prevention programs are appropriately tailored and targeted to include foreign-born women.

“Public health officials in communities with large female non-US-born populations should consider developing HIV prevention messages that are culturally and linguistically appropriate and deliver them through venues where foreign-born populations have reported feeling secure, such as schools, churches, and community centers,” she said.

The same holds true for providers who see patients with HIV, she said.

The study is titled, “Unequal Declines in Absolute and Relative Disparities in HIV Diagnoses Among Black Women, United States, 2008 to 2016.” It was published last month in the American Journal of Public Health. 

This article was originally published by MD Magazine.

Stay up to date on the latest news in specialty pharmacy by getting Specialty Pharmacy Times in your mailbox or inbox for free!

Click here to sign up for free for the bi-monthly Specialty Pharmacy Times print journal delivered to your address.

Click here to sign up for our email newsletters delivered every Monday, Wednesday, and Friday, in addition to breaking news alerts.

Click here to follow us on Facebook. 

Click here to follow us on Twitter. 

Click here to join our LinkedIn group. 

Related Articles

Top news of the day from across the health care landscape.
Research highlights the importance of reaching non-white and younger populations with skin cancer prevention messages.
Top news of the day from across the health care landscape.
Company Profile >
Industry Guide >
Market News >
Peer Exchange >
Conferences >
Subscribe >
Specialty Times Resources
About Us
Contact Us
Terms & Conditions
MJH Associates >
Pharmacy Times
American Journal of Managed Care
MD Magazine
Targeted Oncology
Physicians' Education Resource
Pharmacy & Healthcare Communications, LLC
2 Clarke Drive
Suite 100
Cranbury, NJ 08512
P: 609-716-7777
F: 609-716-4747

Copyright Specialty Pharmacy Times 2006-2019
Pharmacy & Healthcare Communications, LLC. All Rights Reserved.